Adhera Financial Statements From 2010 to 2024

ATRXDelisted Stock  USD 0.72  0.00  0.00%   
Adhera Therapeutics financial statements provide useful quarterly and yearly information to potential Adhera Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Adhera Therapeutics financial statements helps investors assess Adhera Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Adhera Therapeutics' valuation are summarized below:
Adhera Therapeutics does not presently have any fundamental signals for analysis.
Check Adhera Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adhera Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Adhera financial statements analysis is a perfect complement when working with Adhera Therapeutics Valuation or Volatility modules.
  
This module can also supplement various Adhera Therapeutics Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Adhera Therapeutics Company Number Of Shares Shorted Analysis

Adhera Therapeutics' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Shares Shorted

 = 

Shorted by Public

+

by Institutions

More About Number Of Shares Shorted | All Equity Analysis

Current Adhera Therapeutics Number Of Shares Shorted

    
  2.05 K  
Most of Adhera Therapeutics' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adhera Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Competition

Based on the recorded statements, Adhera Therapeutics has 2.05 K of outstending shares currently sold short by investors. This is 99.94% lower than that of the Biotechnology sector and 99.96% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 99.96% higher than that of the company.

Adhera Therapeutics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Adhera Therapeutics's current stock value. Our valuation model uses many indicators to compare Adhera Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adhera Therapeutics competition to find correlations between indicators driving Adhera Therapeutics's intrinsic value. More Info.
Adhera Therapeutics is rated fifth in return on asset category among its peers. It is the top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Adhera Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Adhera Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Adhera Therapeutics Financial Statements

Adhera Therapeutics investors use historical fundamental indicators, such as Adhera Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Adhera Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana. Adhera Therapeutics is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Adhera Pink Sheet

If you are still planning to invest in Adhera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adhera Therapeutics' history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stocks Directory
Find actively traded stocks across global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital